Effect of Metoclopramide on Gastric Volume and Nausea and Vomiting in Fasted Patients Undergoing Elective Cesarean Delivery: A Randomized Clinical Equivalence Trial

( Int J Obstet Anesth . 2025;64:104754. doi:10.1016/j.ijoa.2025.104754) Current obstetric anesthesia guidelines recommend preoperative fasting and aspiration prophylaxis, including metoclopramide, despite limited contemporary evidence supporting its benefit in low-risk, fasted parturients. Given the medication’s known side-effect profile, its routine use in this population warrants further examination. In this study, the authors conducted a randomized, double-blind, placebo-controlled equivalence trial that evaluated whether intravenous (IV) metoclopramide meaningfully reduces gastric volume or improves nausea and vomiting outcomes in appropriately fasted patients undergoing elective cesarean delivery (CD).

Authors

Publication Details

Journal
Obstetric Anesthesia Digest
Published
2026-11-18
DOI
https://doi.org/10.1097/01.aoa.0001288944.21906.a7
Primary Topic
Nausea and vomiting management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Effect of Metoclopramide on Gastric Volume and Nausea and Vomiting in Fasted Patients Undergoing Elective Cesarean Delivery: A Randomized Clinical Equivalence Trial

PE Ripchik, MB Troughton, RJ McCarthy, AG Samworth et al.
1 links
Obstetric Anesthesia Digest
Nausea and vomiting management
article

Effect of Metoclopramide on Gastric Volume and Nausea and Vomiting in Fasted Patients Undergoing Elective Cesarean Delivery: A Randomized Clinical Equivalence Trial

PE Ripchik, MB Troughton, RJ McCarthy, AG Samworth, CL Thomas, SF Lu, JH Kruse, P Toledo, CE Lopez, JM Banayan, IN Gaston
article en

Abstract

( Int J Obstet Anesth . 2025;64:104754. doi:10.1016/j.ijoa.2025.104754) Current obstetric anesthesia guidelines recommend preoperative fasting and aspiration prophylaxis, including metoclopramide, despite limited contemporary evidence supporting its benefit in low-risk, fasted parturients. Given the medication’s known side-effect profile, its routine use in this population warrants further examination. In this study, the authors conducted a randomized, double-blind, placebo-controlled equivalence trial that evaluated whether intravenous (IV) metoclopramide meaningfully reduces gastric volume or improves nausea and vomiting outcomes in appropriately fasted patients undergoing elective cesarean delivery (CD).

Obstetric Anesthesia DigestVol. 46(4)
Good health and well-being
Nausea and vomiting management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon